Product Code: ETC13360164 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
Global Human Microbiome-Based Drugs and Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Human Microbiome-Based Drugs and Diagnostics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Global Human Microbiome-Based Drugs and Diagnostics Market - Industry Life Cycle |
3.4 Global Human Microbiome-Based Drugs and Diagnostics Market - Porter's Five Forces |
3.5 Global Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.7 Global Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Diagnostic Category, 2021 & 2031F |
3.8 Global Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Target Organism, 2021 & 2031F |
3.9 Global Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.10 Global Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Global Human Microbiome-Based Drugs and Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Human Microbiome-Based Drugs and Diagnostics Market Trends |
6 Global Human Microbiome-Based Drugs and Diagnostics Market, 2021 - 2031 |
6.1 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Probiotics, 2021 - 2031 |
6.1.3 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Prebiotics, 2021 - 2031 |
6.1.4 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Symbiotics, 2021 - 2031 |
6.1.5 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Fecal Transplant, 2021 - 2031 |
6.2 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Microbial Profiling, 2021 - 2031 |
6.2.3 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Microbial DNA Testing, 2021 - 2031 |
6.2.4 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021 - 2031 |
6.2.5 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Genomic Profiling, 2021 - 2031 |
6.3 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Gut Microbiome, 2021 - 2031 |
6.3.3 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Oral Microbiome, 2021 - 2031 |
6.3.4 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Skin Microbiome, 2021 - 2031 |
6.3.5 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Vaginal Microbiome, 2021 - 2031 |
6.4 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Gastrointestinal Health, 2021 - 2031 |
6.4.3 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Oral Health, 2021 - 2031 |
6.4.4 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Dermatological Disorders, 2021 - 2031 |
6.4.5 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Immune Modulation, 2021 - 2031 |
6.5 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Digestive Disorders, 2021 - 2031 |
6.5.3 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Periodontal Disease, 2021 - 2031 |
6.5.4 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Skin Health, 2021 - 2031 |
6.5.5 Global Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Vaginal Health, 2021 - 2031 |
7 North America Human Microbiome-Based Drugs and Diagnostics Market, Overview & Analysis |
7.1 North America Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 - 2031 |
7.2 North America Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
7.4 North America Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
7.5 North America Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
7.6 North America Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.7 North America Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market, Overview & Analysis |
8.1 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
8.4 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
8.5 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
8.6 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
8.7 Latin America (LATAM) Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
9 Asia Human Microbiome-Based Drugs and Diagnostics Market, Overview & Analysis |
9.1 Asia Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
9.4 Asia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
9.5 Asia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
9.6 Asia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
9.7 Asia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
10 Africa Human Microbiome-Based Drugs and Diagnostics Market, Overview & Analysis |
10.1 Africa Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
10.4 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
10.5 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
10.6 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
10.7 Africa Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
11 Europe Human Microbiome-Based Drugs and Diagnostics Market, Overview & Analysis |
11.1 Europe Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
11.4 Europe Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
11.5 Europe Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
11.6 Europe Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
11.7 Europe Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
12 Middle East Human Microbiome-Based Drugs and Diagnostics Market, Overview & Analysis |
12.1 Middle East Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Drug Category, 2021 - 2031 |
12.4 Middle East Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Diagnostic Category, 2021 - 2031 |
12.5 Middle East Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Target Organism, 2021 - 2031 |
12.6 Middle East Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
12.7 Middle East Human Microbiome-Based Drugs and Diagnostics Market, Revenues & Volume, By End Use, 2021 - 2031 |
13 Global Human Microbiome-Based Drugs and Diagnostics Market Key Performance Indicators |
14 Global Human Microbiome-Based Drugs and Diagnostics Market - Export/Import By Countries Assessment |
15 Global Human Microbiome-Based Drugs and Diagnostics Market - Opportunity Assessment |
15.1 Global Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
15.3 Global Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Diagnostic Category, 2021 & 2031F |
15.4 Global Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Target Organism, 2021 & 2031F |
15.5 Global Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Application Area, 2021 & 2031F |
15.6 Global Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By End Use, 2021 & 2031F |
16 Global Human Microbiome-Based Drugs and Diagnostics Market - Competitive Landscape |
16.1 Global Human Microbiome-Based Drugs and Diagnostics Market Revenue Share, By Companies, 2024 |
16.2 Global Human Microbiome-Based Drugs and Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |